A prognostic signature consisting of metabolism-related genes and SLC17A4 serves as a potential biomarker of immunotherapeutic prediction in prostate cancer

A prognostic signature consisting of metabolism-related genes and SLC17A4 serves as a potential biomarker of immunotherapeutic prediction in prostate cancer

BackgroundProstate cancer (PCa), a prevalent malignant cancer in males worldwide, screening for patients might benefit more from immuno-/chemo-therapy remained inadequate and challenging due to the heterogeneity of PCa patients. Thus, the study aimed to explore the metabolic (Meta) characteristics a...

Full description

Bibliographic Details
Main Authors: He Li, Jie Gu, Yuqiu Tian, Shuyu Li, Hao Zhang, Ziyu Dai, Zeyu Wang, Nan Zhang, Renjun Peng
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Immunology
Subjects:
prostate cancer
metabolism
prognostic model
immuno-/chemotherapy response
immune infiltration
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.982628/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.982628/full

Similar Items